Constellation Healthcare Tech’s (CHT) “corporate” Rating Reiterated at FinnCap
Constellation Healthcare Tech Inc (LON:CHT)‘s stock had its “corporate” rating reiterated by investment analysts at FinnCap in a research note issued on Friday.
Constellation Healthcare Tech (LON:CHT) traded down 2.09% during midday trading on Friday, hitting GBX 211.00. The stock had a trading volume of 32,000 shares. Constellation Healthcare Tech has a 12-month low of GBX 126.00 and a 12-month high of GBX 257.00. The company’s market cap is GBX 176.88 million. The company has a 50-day moving average price of GBX 194.63 and a 200-day moving average price of GBX 158.88.
ILLEGAL ACTIVITY NOTICE: This article was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The original version of this article can be accessed at https://www.thecerbatgem.com/2016/11/25/constellation-healthcare-tech-inc-cht-earns-corporate-rating-from-finncap.html.
Constellation Healthcare Tech Company Profile
Constellation Healthcare Technologies, Inc is a healthcare services organization providing outsourced business services to the physician market. The Company operates through three operating segments: Revenue Cycle Management (RCM), Practice Management (PM) and Group Purchasing Organization (GPO). The RCM segment offers medical billing and collections, practice management, and other related services to hospital-based and office-based physicians, allowing them to focus on patient care in specialties, such as pathology, anesthesiology, radiology, cardiology, family practice, internal medicine, orthopedics, neurology and emergency medicine.
Receive News & Stock Ratings for Constellation Healthcare Tech Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellation Healthcare Tech Inc and related stocks with our FREE daily email newsletter.